These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31274373)

  • 1. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
    Pontillo ARN; Detsi A
    Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
    Chaiyasan W; Srinivas SP; Tiyaboonchai W
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Random Triblock Copolymers for Sustained Delivery of Macromolecules for the Treatment of Ocular Diseases.
    Ngatuni MJ; Trinh HM; Pal D; Mitra AK
    AAPS PharmSciTech; 2018 Nov; 19(8):3871-3885. PubMed ID: 30306402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption enhancement strategies in chitosan-based nanosystems and hydrogels intended for ocular delivery: Latest advances for optimization of drug permeation.
    Dmour I
    Carbohydr Polym; 2024 Nov; 343():122486. PubMed ID: 39174104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.
    Arafa MG; Girgis GNS; El-Dahan MS
    Int J Nanomedicine; 2020; 15():1335-1347. PubMed ID: 32184589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular application of chitosan.
    Başaran E; Yazan Y
    Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of chitosan modified poly lactic co-glycolic acid biodegradable nanoparticles following oral delivery of gentamicin in rabbits.
    Akhtar B; Muhammad F; Aslam B; Saleemi MK; Sharif A
    Int J Biol Macromol; 2020 Dec; 164():1493-1500. PubMed ID: 32735923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery.
    Bhattarai N; Ramay HR; Chou SH; Zhang M
    Int J Nanomedicine; 2006; 1(2):181-7. PubMed ID: 17722534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration.
    Pandit J; Sultana Y; Aqil M
    Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive biodegradable nanoparticles-in-nanofibers single-dose ocular insert: in vitro, ex vivo and in vivo evaluation.
    Khalil IA; Ali IH; El-Sherbiny IM
    Nanomedicine (Lond); 2019 Jan; 14(1):33-55. PubMed ID: 30543484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.